<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=windows-1252">
<META NAME="Generator" CONTENT="Microsoft Word 97">
<TITLE>Life Science Innovation Cafe</TITLE>
</HEAD>
<BODY LINK="#0000ff">
<FONT SIZE=2>Life Science Innovation Cafe
Confidence in Safety
InnovationWell, </FONT><A HREF="http://innovationwell.net/"><FONT SIZE=2>http://innovationwell.net/</FONT><FONT SIZE=2>
2-6pm, Tuesday, November 8, Basel, Switzerland
moderated by Victor Newman (Knowledgeworks)
For any drug on the market the key question with regards to safe use is: Can we assess how much of the medically relevant safety profile is known? At what point(s) in time? How much remains unknown? The reductive approach to drug development pre-supposes a scope of what needs to be known and proceeds to answer questions within those boundaries. Alternatively, "Confidence in Safety" assumes that all medically relevant information needs to be known, but that we cannot realistically presume to have such complete knowledge until late in a product’s lifecycle, if ever. In order to assess the risk associated with a marketed product we need to be able to assess how much we know about a drug’s safety profile or, more importantly, how much is not known.
Innovation Café workshops demonstrate a new kind of conversation that quickly leads to documented, useable tactics in authentic language.
This Innovation Café will involve participants in two types of innovation thinking about Confidence in Safety by:
1) Inviting participants (InnovationWell members, Biovalley organisations, community of practice meeting attendees) to visualize a scenario where optimum confidence in safety has been realized, and then work backwards to define and prioritize the necessary capabilities that need to be constructed to make it happen;
2) Using reversal-thinking to pose questions about innovation failure to identify what we know intuitively works, now; and turn it into usable knowledge to make the capabilities developed in the success visualization a reality.
Booking
Attendance at this half day workshop on November 8 in Basel can be booked as an individual item; it preceeds the InnovationWell Community of Practice meeting running 9-10 November 2005 in Basel. A place can be reserved through the Online Ticket Office available after login to the InnovationWell website at </FONT><A HREF="http://innovationwell.net/"><FONT SIZE=2>http://innovationwell.net/</FONT><FONT SIZE=2>, or through contacting Barry Hardy, InnovationWell Community of Practice Manager (+41 61 851 0170, innovationwell at douglasconnect.com). On-site or single organisation innovation cafes at your own organisation can also be arranged through enquiry.
About Victor Newmann
Victor Newman was Pfizer's Chief Learning Officer (2000-2004). His leadership of innovation in the form of pragmatic solutions that connect knowledge in new ways, transformed global best-practice. His leadership of skunkworks projects doubled Pfizer's R&D productivity. Victor has a prevailing interest in the psychology of implementation, derived from diverse and intense consulting experience with all industrial sectors.
His recent application of his influential "BoxLogic" KM technique designed to develop a portfolio of innovative strategies, by exploring the limitations of the existing business paradigm within Pfizer, identified key strategic opportunities to transform business strategy and change the basis of measuring and creating new market value.
As Visiting Professor in KM and Innovation, he leads the Lifesciences MBA Consortium in partnership with the Open University Business School in Europe. Victor has contributed to HBR, is author of "Made to Measure Problem Solving" and his "Knowledge Activist's Handbook" from Capstone/ Wiley & Sons was recently cited as the "best management book within the last ten years".
</FONT></BODY>
</HTML>
